MiNK Therapeutics INKT Income Statement (2020-2026)

NASDAQ INKT
$11.62 +0.27 (+2.38%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter)
2.42M2.60M3.36M3.37M3.38M3.39M3.43M3.45M3.45M3.46M3.47M3.94M3.95M3.96M3.97M3.99M4.60M4.71M4.97M5.10M
Operating items
Research & Development (Quarter)
3.33M3.95M5.28M5.88M6.15M5.81M4.19M4.56M3.43M3.31M2.55M1.84M0.54M1.41M1.26M1.84M1.14M1.51M1.20M1.89M
Selling, General & Administrative (Quarter)
0.81M2.36M2.10M1.82M1.84M2.08M1.66M1.78M1.80M2.19M1.28M1.06M1.16M0.81M1.27M1.85M1.85M1.76M1.68M1.33M
Operating Expenses (Quarter)
4.15M6.31M7.37M7.70M7.99M7.89M5.85M6.34M5.22M5.50M3.83M2.90M1.70M2.21M2.53M3.69M2.99M3.28M2.88M3.22M
Operating Income (Quarter)
-13.38M-6.36M-7.37M-7.70M-7.99M-7.89M-5.85M-6.34M-5.22M-5.50M-3.83M-3.07M-1.89M-2.50M-2.70M-4.05M-3.18M-2.71M-2.88M-3.22M
EBIT (Quarter)
-13.38M-6.36M-7.37M-7.70M-7.99M-7.89M-5.85M-6.34M-5.22M-5.50M-3.83M-3.07M-1.89M-2.50M-2.70M-4.05M-3.18M-2.71M-2.88M-3.22M
Non-operating items
Interest & Investment Income (Quarter)
0.03M0.06M0.11M0.07M0.04M0.03M0.08M0.14M0.09M0.07M
Other Non Operating Income (Quarter)
-0.36M0.60M-0.40M1.56M1.56M-0.02M8.00-18.000.33M85.00-0.08M-0.19M0.24M-0.01M0.06M0.02M
Net income details
EBT (Quarter)
-21.45M-7.17M-13.13M-10.96M-12.65M-7.90M-9.90M-10.81M-7.53M-5.45M-3.79M-5.11M-3.29M-2.51M-2.63M-5.41M-9.32M-2.45M-2.79M-7.47M
Profit After Tax (Quarter)
-13.72M-5.60M-7.78M-6.11M-7.71M-7.98M-5.69M-6.20M-5.03M-5.44M-3.81M-2.70M-1.87M-2.22M-2.77M-4.24M-2.89M-2.54M-2.74M-3.13M
Income from Continuing Operations (Quarter)
-21.45M-7.17M-13.13M-10.96M-12.65M-7.90M-9.90M-10.81M-7.53M-5.45M-3.79M-5.11M-3.29M-2.51M-2.63M-5.41M-9.32M-2.45M-2.79M-7.47M
Consolidated Net Income (Quarter)
-21.45M-7.17M-13.13M-10.96M-12.65M-7.90M-9.90M-10.81M-7.53M-5.45M-3.79M-5.11M-3.29M-2.51M-2.63M-5.41M-9.32M-2.45M-2.79M-7.47M
Income towards Parent Company (Quarter)
-21.45M-7.17M-13.13M-10.96M-12.65M-7.90M-9.90M-10.81M-7.53M-5.45M-3.79M-5.11M-3.29M-2.51M-2.63M-5.41M-9.32M-2.45M-2.79M-7.47M
Net Income towards Common Stockholders (Quarter)
-21.45M-7.17M-13.13M-10.96M-12.65M-7.90M-9.90M-10.81M-7.53M-5.45M-3.79M-5.11M-3.29M-2.51M-2.63M-5.41M-9.32M-2.45M-2.79M-7.47M
Additional items
EPS (Basic) (Quarter)
-8.86-2.75-3.92-3.26-3.75-2.35-2.92-3.14-2.18-1.59-1.09-1.38-0.83-0.66-0.66-1.36-2.10-0.57-0.58-1.49
EPS (Diluted) (Quarter)
-8.86-2.75-3.92-3.26-3.75-2.35-2.92-3.14-2.18-1.59-1.09-1.38-0.83-0.66-0.66-1.36-2.10-0.57-0.58-1.49
Shares Outstanding (Quarter)
2.42M2.60M3.35M3.36M3.38M3.37M3.40M3.44M3.45M3.44M3.46M3.71M3.95M3.77M3.96M3.98M4.44M4.27M4.80M5.02M
Shares Outstanding (Diluted) (Quarter)
2.42M2.60M3.35M3.36M3.38M3.37M3.40M3.44M3.45M3.44M3.46M3.71M3.95M3.77M3.96M3.98M4.44M4.27M4.80M5.02M
EBITDA (Quarter)
-13.38M-6.36M-7.37M-7.70M-7.99M-7.89M-5.85M-6.34M-5.22M-5.50M-3.83M-3.07M-1.89M-2.50M-2.70M-4.05M-3.18M-2.71M-2.88M-3.22M
Interest Expenses (Quarter)
8.08M0.81M5.76M3.26M4.66M0.01M4.05M4.47M2.30M-0.05M-0.01M2.10M1.51M0.08M-0.03M1.38M6.22M-0.12M-0.00M4.33M